Street Calls of the Week
NEW YORK - DIH Holding US, Inc. (NASDAQ:DHAI), a provider of robotic rehabilitation devices with annual revenue of $69.57M, announced Monday the appointment of Barrett Mooney, Ph.D. to its Board of Directors. The company’s shares currently trade at $0.22, down 90.4% over the past year.
Mooney brings experience in growing manufacturing businesses and has previously served as CEO and Chairman of a NYSE American-listed aerospace and defense company. He also co-founded HydroBio Inc., a software company later sold to The Climate Corporation in 2017.
His background includes leading international deployment of artificial intelligence tools at CropIn Technology Solutions and directing technology teams for agricultural retail entities. Mooney holds a doctorate in Engineering from the University of Florida.
"Barrett brings exceptional operational expertise and extensive experience in scaling complex manufacturing and technology businesses," said Jason Chen, CEO of DIH, according to the company’s press release.
Mooney stated he looks forward to "working with management and fellow board members to support the company’s continued innovation."
With Mooney’s addition, DIH’s Board now consists of seven members, including five independent directors.
DIH develops robotic devices that incorporate visual stimulation for rehabilitation of patients with walking impairments, balance issues, and impaired arm and hand functions.
The information in this article is based on a press release statement from DIH Holding US, Inc.
In other recent news, DIH Holding US, Inc. is facing a potential delisting from the Nasdaq Stock Market after failing to meet the $50 million market value of listed securities required for continued listing. The company was given until September 1, 2025, to address this issue but has yet to comply. In an effort to strengthen its leadership, DIH has made several strategic appointments to its board. Scott R. Burell, a seasoned healthcare finance veteran currently serving as CFO of AIVITA Biomedical, has joined the board. Additionally, Dennis Streppa, with a robust background in operations and mergers and acquisitions, has been appointed as the Audit Committee Chair. Furthermore, DIH has expanded its Scientific Advisory Board with the addition of Professor Nick Ward, an expert in stroke rehabilitation. These appointments aim to enhance DIH’s governance and advisory capabilities as it navigates its current challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.